Clinical Trial Update: Assessment of Proactive Treatments in Patients With Wet Age-related Macular Degeneration (wAMD) Which Have Never Undergone Treatment of This Particular Disease

View source ↗

Summary

This clinical trial update reports the completion of a Bayer-sponsored study evaluating proactive treatments for patients with wet age-related macular degenerat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Snippet

Sponsor: Bayer | Conditions: Wet Age-related Macular Degeneration | Status: COMPLETED